SCHEMBL2927784

SCHEMBL2927784

CCN1CCN(c2cc(F)cc(C(F)(F)F)c2)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 2/20 0.47
ADRB1 P08588 1/20 0.46
FFAR4 Q5NUL3 1/20 0.46
CHRNA7 P36544 1/20 0.45
GAA P10253 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
MAPT P10636 3/20 0.42
RAD52 P43351 2/20 0.42
KDM4E B2RXH2 1/20 0.42
GFER P55789 1/20 0.42
CHRM4 P08173 1/20 0.41
CHRM1 P11229 1/20 0.41
SIGMAR1 Q99720 2/20 0.41
ALDH1A1 P00352 2/20 0.40
KDM2B Q8NHM5 2/20 0.39
LMNA P02545 2/20 0.39
XBP1 P17861 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
HSD17B10 Q99714 1/20 0.39
CYP1A2 P05177 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2928287 0.90 ADRB1 (0.56) METADRB1FFAR4CHRNA7GAA
SCHEMBL2923960 0.88 ALDH1A1 (0.52) ADRB1FFAR4SMN1; SMN2MAPTSIGMAR1
SCHEMBL2927838 0.85 DRD2 (0.46) ADRB1FFAR4GAASMN1; SMN2KDM4E
SCHEMBL6927640 0.85 CHRNA7 (0.55) CHRNA7GAASMN1; SMN2MAPTRAD52
SCHEMBL10104316 0.84 FFAR4 (0.48) METADRB1FFAR4CHRNA7GAA
SCHEMBL2311467 0.83 GAA (0.53) METADRB1CHRNA7GAASMN1; SMN2
SCHEMBL2926788 0.83 CHRM4 (0.48) METADRB1FFAR4CHRNA7GAA
SCHEMBL18255830 0.82 ADRB1 (0.50) METADRB1FFAR4GAASMN1; SMN2
SCHEMBL18255013 0.79 ADRB1 (0.50) ADRB1FFAR4SMN1; SMN2MAPTSIGMAR1
SCHEMBL1135082 0.79 CHRM4 (0.50) FFAR4CHRNA7MAPTCHRM4CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE41315-E1 Modulators of dopamine neurotransmission NSAB, FILIAL AF NEUROSEARCH SWEDEN AB (DE) 2010-05-04 US disclosed
US-6924374-B2 Central nervous system disorders; psychological disorders A. CARLSSON RESEARCH AB (SE) 2005-08-02 US disclosed
EP-1419773-A2 4-Phenylpiperidine derivatives as modulators of dopamine neurotransmission A. Carlsson Research AB (SE) 2004-05-19 EP disclosed
EP-1240143-A1 NEW MODULATORS OF DOPAMINE NEUROTRANSMISSION A. Carlsson Research AB (SE) 2002-09-18 EP disclosed
WO-2001046146-A1 NEW MODULATORS OF DOPAMINE NEUROTRANSMISSION A. CARLSSON RESEARCH AB (SE) 2001-06-28 WO disclosed